Neeraj Thakur | Pharmacology | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Neeraj Thakur
Affiliation University of Oklahoma Health Campus
Country United States
Scopus ID 56645996700
Documents 37
Citations 1,149
h-index 20
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards
ORCID 0000-0003-1758-0737

Neeraj Thakur
University of Oklahoma Health Campus, United States

The Innovative Research Award recognizes sustained scholarly excellence, impactful scientific contributions, and innovation in biomedical and pharmaceutical sciences. Neeraj Thakur has established an active research profile focused on advanced drug delivery systems, nanomedicine, pharmaceutical formulations, biomaterials, and translational therapeutic technologies. His published work demonstrates interdisciplinary collaboration across pharmaceutical science, toxicology, and biomedical engineering while contributing to improved therapeutic delivery strategies for dermatological and ocular applications.[1]

Abstract

Neeraj Thakur’s research integrates pharmaceutical sciences, nanotechnology, biomaterials, and targeted therapeutic delivery to address challenges associated with drug stability, controlled release, tissue targeting, and improved clinical efficacy. His work encompasses hybrid micellar systems, ocular nanoformulations, RNA interference technologies, and advanced pharmaceutical carriers designed to improve patient outcomes through innovative formulation strategies.[2]

Keywords

Drug Delivery Systems, Nanomedicine, Hybrid Micelles, RNA Interference, Corneal Therapeutics, Pharmaceutical Sciences, Targeted Drug Delivery

Introduction

Modern pharmaceutical research increasingly focuses on precision drug delivery, sustained therapeutic release, and biomaterial-enabled treatment strategies. Neeraj Thakur’s research aligns with these objectives through the development of multifunctional nanocarriers and advanced pharmaceutical formulations capable of enhancing therapeutic performance while minimizing adverse effects. His publications demonstrate an interdisciplinary approach combining pharmaceutical sciences with materials engineering and translational medicine.[3]

Research Profile

  • Scopus Author ID: 56645996700
  • 37 indexed scholarly publications.
  • 1,149 citations reflecting broad scientific visibility.
  • h-index of 20 demonstrating consistent research influence.
  • Research spans pharmacology, toxicology, pharmaceutical sciences, nanomedicine and biomaterials.

Research Contributions

The research contributions of Neeraj Thakur include the design of crosslinked hybrid micellar systems for cutaneous drug delivery, sustained nanoformulations for corneal wound healing, and RNA interference applications in viral diagnostics and therapeutics. These investigations emphasize formulation optimization, targeted delivery, therapeutic efficiency, and translational biomedical applications while supporting the broader advancement of pharmaceutical technology.[4]

Publications

  • Crosslinked hybrid micellar platform for targeted cutaneous drug delivery
    Colloids and Surfaces B: Biointerfaces (2026). DOI: 10.1016/j.colsurfb.2026.115998
  • Crosslinked Hybrid Micellar Platform for Targeted Cutaneous Drug Delivery
    Preprint (2026). DOI: 10.2139/ssrn.6250431
  • A multimodal approach to smart and sustained drug delivery for corneal wound management: the GelPol nanoformulation
    Nanomedicine (2025). DOI: 10.1080/17435889.2025.2550236
  • RNAi in viral control and diagnostics
    Book Chapter (2025). DOI: 10.1088/978-0-7503-4987-1ch12

Research Impact

The documented citation profile, publication record, and interdisciplinary research portfolio indicate sustained academic influence within pharmaceutical sciences. Contributions toward targeted drug delivery technologies and nanomedicine support ongoing developments in precision therapeutics, controlled release formulations, and biomedical innovation. The citation metrics further demonstrate recognition by the international research community.[1]

Award Suitability

Based on the available scholarly metrics, publication output, interdisciplinary research contributions, and demonstrated impact within pharmaceutical sciences, Neeraj Thakur represents a suitable candidate for recognition through the Innovative Research Award. His research portfolio reflects innovation in drug delivery technologies, sustained scientific productivity, and contributions supporting future translational healthcare solutions.[2]

Conclusion

Neeraj Thakur has established a notable research profile characterized by innovation in pharmaceutical formulation science, targeted therapeutic delivery, nanotechnology, and biomaterial-based treatment strategies. Supported by strong bibliometric indicators and peer-reviewed scholarly publications, his work contributes to the continued advancement of pharmaceutical sciences and biomedical research while reflecting the qualities recognized by the Innovative Research Award.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Neeraj Thakur, Author ID 56645996700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56645996700
  2. Thakur, N. (2026). Crosslinked hybrid micellar platform for targeted cutaneous drug delivery. Colloids and Surfaces B: Biointerfaces.
    https://doi.org/10.1016/j.colsurfb.2026.115998
  3. Thakur, N. (2026). Crosslinked Hybrid Micellar Platform for Targeted Cutaneous Drug Delivery. SSRN Preprint. https://doi.org/10.2139/ssrn.6250431
  4. Thakur, N. (2025). A multimodal approach to smart and sustained drug delivery for corneal wound management: the GelPol nanoformulation. Nanomedicine. https://doi.org/10.1080/17435889.2025.2550236
  5. Thakur, N. (2025). RNAi in viral control and diagnostics. Viral Diseases: History and New Developments in Diagnostics and Therapeutics.
    https://doi.org/10.1088/978-0-7503-4987-1ch12

Paroma Arefin | Pharmaceutical Science | Women Researcher Award

Published on by Academic Achievements

Women Researcher Award

Paroma Arefin
Affiliation University of Houston
Country United States
Scopus ID 57041256700
Documents 15
Citations 67
h-index 6
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards
ORCID 0000-0002-5968-1002

Paroma Arefin

Institution: University of Houston, United States

Paroma Arefin is a researcher whose scholarly work spans pharmaceutical sciences, proton exchange membrane fuel cells, hydrogen energy technologies, biomaterials, and public health research. Her interdisciplinary publications demonstrate contributions to pharmaceutical formulation, sustainable energy systems, healthcare technologies, and consumer health awareness. Through peer-reviewed research, she has participated in studies addressing fuel cell durability, drug delivery systems, mobility assistance technologies, and healthcare education, reflecting an interdisciplinary approach that bridges engineering and pharmaceutical sciences.[1]

Abstract

This article summarizes the academic profile and research achievements of Paroma Arefin in recognition of the Women Researcher Award. Her publications primarily address proton exchange membrane fuel cells, hydrogen-powered transportation, pharmaceutical formulation, biomaterials, and healthcare studies. These contributions demonstrate interdisciplinary scholarship that combines pharmaceutical sciences with emerging sustainable energy technologies and applied healthcare research. Her publication record, citation profile, and collaborative research activities illustrate continued participation in internationally visible scientific literature.[1][2]

Keywords

Women Researcher Award, Paroma Arefin, Pharmaceutical Science, Proton Exchange Membrane Fuel Cell, Hydrogen Energy, Drug Delivery, Biomaterials, Fuel Cell Durability, Healthcare Research, University of Houston.

Introduction

Interdisciplinary scientific research increasingly contributes to addressing global healthcare and energy challenges. Paroma Arefin’s scholarly work reflects this trend through publications involving pharmaceutical formulations, hydrogen fuel cell technology, mobility assistance devices, and public health awareness. Her research integrates engineering concepts with pharmaceutical sciences to explore practical solutions that may contribute to healthcare innovation and sustainable energy development.[2]

Research Profile

  • Affiliation: University of Houston.
  • Research specialization includes Pharmacology, Toxicology and Pharmaceutical Science.
  • Scopus Author ID: 57041256700.
  • Research output includes interdisciplinary studies in pharmaceutical sciences, hydrogen fuel cells and healthcare.
  • Publication metrics include 15 indexed documents, 67 citations and an h-index of 6.

Research Contributions

Paroma Arefin has co-authored review articles examining durability factors affecting proton exchange membrane fuel cells, including the influence of operating temperature and membrane degradation mechanisms. These studies provide comprehensive overviews of hydrogen fuel cell technologies and summarize engineering challenges affecting long-term performance.[3]

Her pharmaceutical research includes formulation and characterization of controlled-release microspheres containing Fexofenadine hydrochloride, contributing to studies on drug delivery systems and controlled pharmaceutical release technologies.[4]

Additional publications address consumer awareness regarding food adulteration, mobility assistive devices for elderly populations, and hydrogen-powered transportation systems, demonstrating broad interdisciplinary engagement across engineering and health sciences.[5]

Publications

  • Effect of temperature on the performance factors and durability of proton exchange membrane of hydrogen fuel cell: A narrative review (2020).
  • Proton exchange membrane fuel cell durability factors, challenges, and future perspectives: A detailed review (2021).
  • Study on awareness about food adulteration and consumer rights among consumers in Dhaka, Bangladesh (2020).
  • Adoption of hydrogen fuel cell vehicles and its prospects for the future: A review (2022).
  • Design, characterization and in vitro evaluation of HPMC K100 M CR loaded Fexofenadine HCl microspheres (2016).
  • A comparison of mobility assistive devices for elderly and patients with lower limb injury: Narrative Review.

Research Impact

Citation indicators demonstrate measurable academic visibility within pharmaceutical science and hydrogen energy research. Review articles concerning proton exchange membrane fuel cells have contributed to knowledge synthesis in sustainable energy technologies, while pharmaceutical formulation studies support advances in controlled drug delivery. Collectively, these works reflect interdisciplinary collaboration and continued scholarly engagement across multiple research domains.[1][3]

Award Suitability

Based on her documented publication record, interdisciplinary collaborations, citation profile, and research contributions spanning pharmaceutical sciences, hydrogen fuel cell technologies, healthcare applications, and public health, Paroma Arefin demonstrates characteristics consistent with recognition through the Women Researcher Award. Her research portfolio illustrates continued scholarly activity, international collaboration, and contributions to scientific literature relevant to sustainable technologies and pharmaceutical innovation.[1]

Conclusion

Paroma Arefin’s academic record demonstrates interdisciplinary scholarship across pharmaceutical science, sustainable energy technologies, healthcare engineering, and biomedical research. Her publications, citation metrics, and collaborative research activities collectively represent meaningful contributions to contemporary scientific literature. The combination of pharmaceutical innovation and engineering-focused sustainability research supports her recognition within international academic award programs.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Paroma Arefin, Author ID 57041256700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57041256700
  2. Salam, M. A., Habib, M. S., Arefin, P., Ahmed, K., Uddin, S., Hossain, T., & Papri, N. (2020).
    Effect of Temperature on the Performance Factors and Durability of Proton Exchange Membrane of Hydrogen Fuel Cell: A Narrative Review.
    Material Science Research India, 17(2), 179–191.
    DOI: https://doi.org/10.13005/msri/170207
  3. Habib, M. S., Arefin, P., Salam, M. A., Ahmed, K., Uddin, M. S., Hossain, T., Papri, N., et al. (2021). Proton Exchange Membrane Fuel Cell (PEMFC) Durability Factors, Challenges, and Future Perspectives: A Detailed Review.
    Material Science Research India, 18(2), 217–234.
    DOI: https://doi.org/10.13005/msri/180209
  4. Arefin, P., Hasan, I., & Reza, M. S. (2016).
    Design, Characterization and In Vitro Evaluation of HPMC K100 M CR Loaded Fexofenadine HCl Microspheres.  SpringerPlus, 5, 691. DOI: https://doi.org/10.1186/s40064-016-2322-2
  5. Habib, M. S., & Arefin, P. (2022).
    Adoption of Hydrogen Fuel Cell Vehicles and Its Prospects for the Future (A Review).
    Oriental Journal of Chemistry, 38(3), 621–631. DOI: https://doi.org/10.13005/ojc/380311

Xinge Du | Architectural Design and Theory | Research Excellence Award

Published on by Academic Achievements

Dr. Xinge Du | Architectural Design and Theory | Research Excellence Award

Tianjin University | China

Dr. Xinge Du (Dylan) is a Ph.D. candidate in Architecture at Tianjin University, specializing in green building, low-carbon campus planning, and building performance optimization. His research integrates sustainable design principles with advanced simulation and BIM technologies to develop practical solutions for energy-efficient built environments. He previously earned his Master’s and Bachelor’s degrees from Taiyuan University of Technology, where he received multiple academic scholarships and honors. Du has published in high-impact journals such as Scientific Reports and Sustainability, contributing innovative frameworks for low-carbon building retrofits and campus design. Actively involved in industry-linked projects, he has led architectural designs incorporating photovoltaic systems and passive energy strategies. His award-winning work in rural housing and campus retrofitting demonstrates a strong commitment to sustainable development and real-world architectural innovation.

Citation Metrics (Scopus)

9

6

3

0

Citations
6

Documents
2

h-index
2

🟦 Citations 🟥 Documents 🟩 h-index

Featured Publications

 

 

Yu-Jin Kim | Agricultural and Biological Sciences | Research Excellence Award

Published on by Academic Achievements

Prof. Dr. Yu-Jin Kim | Agricultural and Biological Sciences | Research Excellence Award

Pusan National University | South Korea

Dr. Yu-Jin Kim is an Associate Professor in the Department of Life Science and Environmental Biochemistry at Pusan National University. She specializes in plant molecular biology, with a focus on functional genomics, reproductive development, and secondary metabolite biosynthesis in crops such as rice and ginseng. Dr. Kim earned her Ph.D. in Herb Genetic Engineering from Kyung Hee University, graduating with outstanding academic performance. Her research has significantly advanced understanding of pollen tube growth, male sterility mechanisms, and stress responses in plants. She has published extensively in high-impact SCI(E) journals and contributed to internationally recognized collaborations. In 2026, she was elected as a member of the Young Korean Academy of Science and Technology (Y-KAST), reflecting her growing influence in plant science and biotechnology research.

Citation Metrics (Scopus)

6000

4500

3000

1500

0

Citations
5,991

Documents
128

h-index
36

🟦 Citations 🟥 Documents 🟩 h-index

Featured Publications

 

 

Elena Dolgikh | Agricultural and Biological Sciences | Research Excellence Award

Published on by Academic Achievements

Dr. Elena Dolgikh | Agricultural and Biological Sciences | Research Excellence Award

ARRIAM | Russia

Dr. Elena Anatolyevna Dolgikh is a leading scientist in plant–microbe interactions and molecular plant biology, currently serving as Head of the Laboratory of Signal Regulation at the All-Russia Research Institute for Agricultural Microbiology, Russia. Her research focuses on rhizobium–plant symbiosis, signal transduction, nodulation, and hormonal regulation in legumes. With over 75 publications indexed in WoS and Scopus, many in Q1 journals, she has made significant contributions to understanding molecular mechanisms underlying nitrogen-fixing symbiosis. Dr. Dolgikh has led nationally and internationally funded projects and collaborated with prominent institutions in the USA, France, and the Netherlands through NATO and FEMS fellowships. A laureate of the Russian Federation Government Prize in Science and Technology, her work has strong societal impact in advancing sustainable agriculture, improving crop productivity, and supporting environmentally friendly biofertilizer development.

Featured Publications

Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicry
– Nature Structural and Molecular Biology (2026) | Citations: 1

 

Annamaria Pratelli | Veterinary Medicine | Research Excellence Award

Published on by Academic Achievements

Prof. Dr. Annamaria Pratelli | Veterinary Medicine | Research Excellence Award

Università degli Studi di Bari – Dipartimento di Medicina Veterinaria | Italy

Prof. Annamaria Pratelli is a Full Professor of Infectious Diseases of Animals at the University of Bari, Italy, and a globally recognized expert in veterinary virology and coronavirus research. She has been listed among the World’s Top 2% Scientists by Stanford University (2022 and 2025) and has contributed significantly to the study of animal coronaviruses and zoonotic diseases. With over 205 peer-reviewed publications, an H-index of 33, and more than 3,100 citations (Scopus, 2026), her work spans viral pathogenesis, epidemiology, and antiviral strategies. She has led multiple nationally funded research projects and actively contributed to SARS-related task forces in collaboration with national health authorities. Prof. Pratelli serves on several international editorial boards and has extensive experience in scientific evaluation and governance, with impactful contributions to One Health and global infectious disease research.

Citation Metrics (Scopus)

3500

2500

1500

500

0

Citations
3,125

Documents
123

h-index
34

🟦 Citations 🟥 Documents 🟩 h-index

Featured Publications

Evidence for evolution of canine parvovirus type 2 in Italy
– Journal of General Virology (2001) | Citations: 854

A canine parvovirus mutant is spreading in Italy
– Journal of Clinical Microbiology (2004) | Citations: 180

Genetic diversity of a canine coronavirus detected in pups with diarrhoea in Italy
– Journal of Virological Methods (2003) | Citations: 155

Development of a nested PCR assay for the detection of canine coronavirus
– Journal of Virological Methods (1999) | Citations: 135

 

Aishwarya R Kurdekar | Pharmaceutical Science | Best Researcher Award

Published on by Academic Achievements

Ms. Aishwarya R Kurdekar |  Pharmaceutical Science | Best Researcher Award

Bapuji pharmacy college | India
Ms. Aishwarya R. Kurdekar is a dedicated Pharmacology Research Scholar at Bapuji Pharmacy College, specializing in anticancer pharmacology, natural product drug discovery, and oxidative stress mechanisms. She holds an M.Pharm in Pharmacology and has contributed to advancing plant-based therapeutic research through both experimental and computational approaches. Her notable publication in Cell and Tissue Biology (Springer Nature) explores the antioxidant and anticancer potential of Argemone mexicana seed extract using HepG2 liver cancer cell lines. Her research integrates in-vitro studies with LC-MS profiling, network pharmacology, and molecular docking to identify bioactive compounds and molecular targets. She has actively collaborated with academic researchers and presented her work at national conferences, earning recognition including a Best E-Poster Award. Her ongoing research focuses on pancreatic cancer (PANC-1) cell lines, aiming to develop safer, effective anticancer strategies with societal impact.

Featured Publications

 

Ravi Maharjan | Pharmaceutics | Best Researcher Award

Published on by Academic Achievements

Dr. Ravi Maharjan | Pharmaceutics | Best Researcher Award

Dr. Ravi Maharjan | Pharmaceutics | Assistant Research Professor at Yonsei University | South Korea

Pharmaceutics is the foundation of Dr. Ravi Maharjan’s distinguished career as a research professor at Yonsei University, Korea, where he has been at the forefront of integrating AI/ML and Digital Twin technologies to revolutionize biopharmaceutical manufacturing, particularly in mRNA and siRNA-based lipid nanoparticle (LNP) vaccine development. Dr. Ravi Maharjan earned his PhD in Pharmaceutics and has since developed a deep expertise in biopharmaceutical process optimization, continuous manufacturing, lyophilization, stabilization strategies, and innovative delivery approaches targeting ocular and brain tissues. His professional experience spans extensive teaching, mentoring, and research leadership roles, where he has guided national and international collaborations with universities, pharmaceutical companies, and research institutions, including Pusan National University, CHA University, RCPE, RNAAnalytics Austria, and IMDEA Spain, demonstrating his ability to bridge academic research with industrial applications. Dr. Ravi Maharjan’s research interests focus on applying AI/ML algorithms for predictive modeling of complex pharmaceutical processes, optimizing formulations, ensuring protein stability, and enhancing the physical and biological stability of therapeutics. His work integrates pharmaceutics, process analytical technologies (PAT), quality by design (QbD), experimental design (DOE), and computational modeling to advance next-generation biopharmaceutical platforms. Among his key research skills are data-driven formulation design, predictive modeling, digital twin deployment, computational optimization of LNP delivery, lyophilized formulation screening, molecular simulation, process monitoring, and the translation of lab-scale research into continuous manufacturing systems. Dr. Ravi Maharjan has an impressive record of scholarly contributions, including over 23 SCIE Q1 publications, two books, two book chapters, more than 115 peer-review assignments, over 30 conference presentations, and eight invited talks. He has served as associate editor for Pharmaceutical Science and Technology (USA), editorial board member for Scientific Reports (Nature Portfolio, UK), Pharmaceutics (Switzerland), and Current Pharmaceutical Biotechnology (UAE), as well as conference organizer for multiple international events. His awards and honors recognize his contributions to both fundamental pharmaceutics and applied biopharmaceutical manufacturing, highlighting his excellence in research innovation and mentorship. Dr. Ravi Maharjan has demonstrated outstanding ability to secure funding, lead interdisciplinary projects, and foster scientific collaboration across countries and institutions, contributing to the advancement of mRNA and siRNA therapeutics, the optimization of excipients, and the improvement of drug delivery systems. His work on digital twins and AI/ML-driven process optimization has paved the way for predictive control in continuous manufacturing, ensuring reproducibility, efficiency, and quality in pharmaceutical production. In conclusion, Dr. Ravi Maharjan embodies the integration of scientific innovation, computational methods, and practical pharmaceutics expertise, making significant impacts in biopharmaceutical sciences, while continuing to mentor the next generation of researchers, drive technological innovation, and advance knowledge in AI-assisted pharmaceutical development.

Profile: Google Scholar

Featured Publications 

  1. Tripathi, J., Thapa, P., Maharjan, R., & Jeong, S. H. (2019). Current state and future perspectives on gastroretentive drug delivery systems. Citations: 246
  2. Maharjan, R., Hada, S., Lee, J. E., Han, H. K., Kim, K. H., Seo, H. J., Foged, C., … (2023). Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach. Citations: 48
  3. Maharjan, R., Kim, K. H., Lee, K., Han, H. K., & Jeong, S. H. (2024). Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches. Citations: 44
  4. Maharjan, R., & Jeong, S. H. (2020). High shear seeded granulation: Its preparation mechanism, formulation, process, evaluation, and mathematical simulation. Citations: 37
  5. Bhujel, R., Maharjan, R., Kim, N. A., & Jeong, S. H. (2021). Practical quality attributes of polymeric microparticles with current understanding and future perspectives. Citations: 29
  6. Maharjan, R., Lee, J. C., Lee, K., Han, H. K., Kim, K. H., & Jeong, S. H. (2023). Recent trends and perspectives of artificial intelligence-based machine learning from discovery to manufacturing in biopharmaceutical industry. Citations: 28
  7. Kim, K. H., Lee, J. E., Lee, J. C., Maharjan, R., Oh, H., Lee, K., Kim, N. A., & Jeong, S. H. (2023). Optimization of HPLCCAD method for simultaneous analysis of different lipids in lipid nanoparticles with analytical QbD. Citations: 17

 

Assoc. Prof. Dr. Iulia Ioan | Medicine | Women Researcher Award

Published on by Academic Achievements

Assoc. Prof. Dr. Iulia Ioan | Medicine | Women Researcher Award

Assoc. Prof. Dr. Iulia Ioan | Medicine – University Hospital of Nancy, France

Dr. Iulia Ioan is a dedicated researcher specializing in pediatric respiratory medicine and sleep disorders. Her work focuses on advancing the understanding and clinical management of respiratory oscillometry, asthma, and obstructive sleep apnea in children and adults. Over recent years, she has established herself as a respected figure in her field, contributing to multidisciplinary collaborations that bridge clinical practice and functional respiratory research. Her continuous output of high-quality research articles and reviews reflects her commitment to improving respiratory health outcomes through innovative diagnostics and treatment strategies.\

Profile Verified:

ORCID | Scopus | Google Scholar

Education:

Dr. Ioan’s academic journey includes advanced medical and scientific training culminating in an MD and PhD, equipping her with a solid foundation in clinical medicine and biomedical research. Her specialized education in functional respiratory explorations has enabled her to develop expertise in pediatric respiratory function testing and clinical sleep medicine, which underpins her research endeavors.

Experience:

With substantial experience in clinical and research settings, Dr. Ioan currently serves at the Service d’Explorations Fonctionnelles Pédiatriques, Hôpital d’Enfants, CHRU de Nancy. Her role involves both direct patient care and leading research projects focused on pediatric respiratory diseases and sleep disorders. Over the years, she has honed skills in polysomnography, respiratory mechanics, and the evaluation of airway diseases, collaborating with national and international teams. Her involvement in translational research facilitates the implementation of novel diagnostic tools into routine clinical practice.

Research Interest:

Dr. Ioan’s research interests encompass respiratory oscillometry, pediatric asthma, sleep apnea syndromes, and the impact of environmental factors such as tobacco smoke on respiratory health. She explores the clinical applications of respiratory function testing technologies and their relevance in diagnosing and managing obstructive airway diseases. Additionally, her work addresses the epidemiology and treatment effectiveness of severe allergic asthma and sleep-related breathing disorders, contributing valuable insights into pediatric pulmonology and sleep medicine.

Awards:

While specific awards are not listed, Dr. Ioan’s profile demonstrates recognition through citations and sustained research output. Her work’s impact on clinical practice and respiratory medicine positions her as a strong candidate for research awards celebrating female scientists. Continued excellence in publication, collaboration, and clinical innovation further strengthens her candidacy for prestigious honors within respiratory and pediatric research communities.

Selected Publications:

  1. 🌬️ “Technical standards for respiratory oscillometry,” European Respiratory Journal, 2020. (Cited by 578) – This pivotal article defines technical guidelines widely used in respiratory function testing.
  2. 💤 “Clinical significance and applications of oscillometry,” European Respiratory Review, 2022. (Cited by 168) – A comprehensive review highlighting oscillometry’s role in respiratory disease assessment.
  3. 🌟 “Asthma and obstructive sleep apnoea in adults and children – an up-to-date review,” Sleep Medicine Reviews, 2022. (Cited by 65) – Integrates current knowledge on the overlap between asthma and sleep apnea.
  4. 🚭 “The impact of tobacco smoking on adult asthma outcomes,” International Journal of Environmental Research and Public Health, 2021. (Cited by 59) – Examines how smoking exacerbates asthma symptoms and treatment outcomes.
  5. 🛌 “Feasibility of parent-attended ambulatory polysomnography in children with suspected obstructive sleep apnea,” Journal of Clinical Sleep Medicine, 2020. (Cited by 31) – Demonstrates the practicality of home-based sleep studies for children.
  6. 🌿 “Real-life effectiveness of benralizumab, mepolizumab and omalizumab in severe allergic asthma associated with nasal polyps,” Clinical Reviews in Allergy & Immunology, 2023. (Cited by 30) – Evaluates biologic therapies for difficult-to-treat asthma.
  7. 🧒 “What is chronic cough in children?” Frontiers in Physiology, 2014. (Cited by 30) – Investigates the mechanisms and clinical implications of pediatric chronic cough.

Conclusion:

Dr. Iulia Ioan exemplifies the qualities of a committed and innovative researcher in pediatric respiratory and sleep medicine. Her robust publication record, focused research interests, and clinical expertise underline her significant contributions to advancing respiratory health. Dr. Ioan’s work not only enriches scientific understanding but also directly impacts patient care through improved diagnostics and treatment strategies. Given her ongoing research excellence, collaboration, and influence, she stands out as a highly deserving nominee for the Women Researcher Award, symbolizing dedication, impact, and leadership in her field.

 

 

 

Eni Bushi | Pharmaceutical | Best Review Paper Award-7740

Published on by Academic Achievements

Dr. Eni Bushi | Pharmaceutical | Best Review Paper Award

Dr. Eni Bushi | Pharmaceutical – PhD student at University of Medicine Tirana, Albania

Eni Bushi (Beçi) is a dynamic pharmaceutical professional and researcher whose work bridges academia and the pharmaceutical industry. With extensive experience in pharmaceutical technology, quality assurance, and public health, she has made significant contributions both as a researcher and a leader in pharmaceutical practice. As the current Head of the Quality Assurance Department at Profarma sh.a. and a faculty member at the University of Medicine in Tirana, she plays a crucial role in shaping drug development standards and mentoring emerging professionals. A member of key scientific bodies such as NanoAlb and the Academy of Pharmacy “Eureka,” she exemplifies a strong commitment to advancing pharmaceutical knowledge through rigorous scientific inquiry and industry innovation.

Profile Verified

Scopus

Education

Eni Bushi holds a Master of Science in Pharmaceutical Sciences from the University of Medicine, Tirana, where she graduated with a perfect GPA and defended a thesis focused on prescription practices among elderly patients. Demonstrating her multidisciplinary outlook, she pursued a Master of Business Administration (MBA) at the University of New York Tirana, concentrating on healthcare management, with a thesis on Lean implementation in health systems. Currently, she is a PhD candidate in Pharmaceutical Technology at the same university, focusing on innovative semisolid formulations and their stability. Her academic journey has been enhanced by international certifications and professional development courses in nanotechnology, analytical validation, and Good Laboratory Practices.

Experience

Professionally, Eni Bushi has cultivated a strong career trajectory from community pharmacy to pharmaceutical manufacturing and research. Starting as a community pharmacist, she developed early experience in patient care and medication management. She then transitioned to Profarma sh.a., where she rose from Specialist to Head of the Quality Assurance Department, leading regulatory compliance, validation processes, and interdepartmental coordination. Simultaneously, she has served as a laboratory assistant and research mentor at the University of Medicine in Tirana. Her industry-academic hybrid role enables her to influence both pharmaceutical practice and education, while also fostering research innovation in drug development and regulatory science.

Research Interest

Eni Bushi’s research interests center on pharmaceutical technology, quality systems, antimicrobial resistance, and health systems improvement. Her current doctoral research focuses on semisolid drug formulations, with an emphasis on their physicochemical stability and comparative efficacy. She is particularly interested in integrating nanotechnology into drug delivery systems, and has pursued specialized training in nanomedicine. Her previous studies have explored the knowledge and behavior surrounding antibiotic use, as well as Lean strategies in healthcare environments. These interdisciplinary themes reflect her goal of advancing public health outcomes through innovation in drug formulation and pharmaceutical services.

Awards

Throughout her academic and professional journey, Eni Bushi has received recognition for her academic excellence and leadership. She was awarded the “Excellent Student” distinction by the University of Tirana’s Rectorate and has been consistently invited to contribute to international forums and scientific conferences. Her nomination for the Best Review Paper Award is underpinned by a record of impactful publications, academic mentorship, and a leadership role in pharmaceutical quality assurance.

Selected Publications

  1. 📘 Evaluation of the Knowledge, Attitude and Public Awareness about the Use of Antibiotic and Antibiotic Resistance in Albania (2024) – Indian Journal of Pharmaceutical Education and Research. Cited by 6 articles.
  2. 🧴 Formulation, Preparation and Evaluation of a Natural Cosmetic Product (2023) – Albanian Journal of Medical and Health Sciences. Cited by 3 articles.
  3. 🏥 Using Expert Consensus to Evaluate the Readiness Factors of Lean Implementation in Healthcare (2022) – International Journal of Scientific Research and Management. Cited by 9 articles.
  4. 👵 Prevalence and Factors Associated with Potentially Inappropriate Prescriptions among Older Patients at Hospital Discharge in Albania (2016) – Journal of Evaluation in Clinical Practice. Cited by 28 articles.
  5. 🧪 Theoretical Aspects of the Application of “Quality by Design” Approach in Drug Formulation (2025, Thesis Supervision) – Unpublished.
  6. 💊 Prevalence Assessment and Analysis of Self-Reported Use of Stimulant and Sedative Drugs among University Students (2023, Thesis Supervision) – University of Medicine, Tirana.
  7. 🧬 Analysis on the Level of Knowledge, Attitude, and Public Awareness Towards the Use of Antibiotics and Antimicrobial Resistance (2021, Thesis Supervision) – University of Medicine, Tirana.

Conclusion

Eni Bushi demonstrates a strong and evolving profile as a researcher, practitioner, and academic leader in the field of pharmaceutical sciences. Her combined background in pharmacy, business management, and pharmaceutical technology positions her uniquely to contribute to transformative change in drug formulation, health policy, and quality assurance. Her dedication to innovation, public health, and regulatory science makes her a highly deserving candidate for the Best Review Paper Award. Her work not only exemplifies academic excellence but also provides practical value to both the pharmaceutical industry and healthcare systems in Albania and beyond.